Dr. Vanvaerenbergh Saskia, huisarts
0821.579.310 · rovalta.com · 25/09/2026
NORMAL SITUATION
Dr. Vanvaerenbergh Saskia, huisarts
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result-1,5 k €+90,7 %over 1 year
Gross margin35,5 k €+297,8 %over 1 year
Equity95 k €-1,5 %over 1 year
Overview
Identity
Source · BCE/KBODr. Vanvaerenbergh Saskia, huisarts is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.579.310
- Legal form
- Private limited company
- Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Signals
Solid equity
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 35,5 k € | +298% | -18 k € | +49.9% | -35,8 k € | -170% | 50,8 k € | -31.3% | 74 k € |
| EBITDA | -2,8 k € | +85.3% | -19 k € | +48.3% | -36,7 k € | -174% | 49,4 k € | -32.7% | 73,4 k € |
| Operating result | -2,8 k € | +88.5% | -24,3 k € | +46.3% | -45,3 k € | -212% | 40,5 k € | -41.6% | 69,4 k € |
| Net result | -1,5 k € | +90.7% | -15,9 k € | +63.9% | -44,2 k € | -242% | 31,2 k € | -38.6% | 50,7 k € |
| Balance sheet | |||||||||
| Equity | 95 k € | -1.5% | 96,4 k € | -28.5% | 134,9 k € | -24.7% | 179,1 k € | -6.2% | 190,9 k € |
| Total assets | 95 k € | -5.8% | 100,8 k € | -26.7% | 137,4 k € | -23.9% | 180,5 k € | -6.9% | 193,8 k € |
| Cash | 1,3 k € | -88.8% | 11,7 k € | -50.7% | 23,8 k € | -61.1% | 61,3 k € | -36.6% | 96,7 k € |
| Debts | 0 € | -100% | 4,3 k € | +73.2% | 2,5 k € | +72.4% | 1,4 k € | -50.1% | 2,9 k € |
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
Saskia VANVAERENBERGH
ActiveEnded mandates
SASKIA VAN VAERENBERGH
EndedSASKIA VANVAERENBERGH
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/10/2020 | 01/10/2019 | 01/10/2018 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 30/09/2020 | 30/09/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 15 months | 12 months | 12 months |
| Filing date | 31/03/2025 | 25/09/2024 | 29/09/2023 | 17/10/2022 | 30/04/2021 | 29/05/2020 |
| General meeting | 06/02/2025 | 19/09/2024 | 12/06/2023 | 13/06/2022 | 08/03/2021 | 09/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 06/02/2025 | 31/03/2025 | Dutch | |
| Micro model | 31/12/2023 | 19/09/2024 | 25/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 12/06/2023 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/06/2022 | 17/10/2022 | Dutch | |
| Micro model | 30/09/2020 | 08/03/2021 | 30/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 09/03/2020 | 29/05/2020 | Dutch | |
| Micro model | 30/09/2018 | 11/03/2019 | 08/05/2019 | Dutch | |
| Micro model | 30/09/2017 | 12/03/2018 | 16/05/2018 | Dutch | |
| Abridged model | 30/09/2016 | 13/03/2017 | 05/04/2017 | Dutch | |
| Abridged model | 30/09/2015 | 14/03/2016 | 10/05/2016 | Dutch | |
| Abridged model | 30/09/2014 | 09/03/2015 | 07/04/2015 | Dutch | |
| Abridged model | 30/09/2013 | 10/03/2014 | 27/03/2014 | Dutch | |
| Abridged model | 30/09/2012 | 11/03/2013 | 30/04/2013 | Dutch | |
| Abridged model | 30/09/2011 | 12/03/2012 | 02/05/2012 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
Saskia VANVAERENBERGH
ActiveEnded mandates
SASKIA VAN VAERENBERGH
EndedSASKIA VANVAERENBERGH
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution24/03/2025RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Mandates24/12/2020WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
- Registered office02/02/2015MAATSCHAPPELIJKE ZETEL
- Other23/05/2012STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other22/12/2009RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-1,5 k €↑
- 2023Annual accounts 2023-15,9 k €↑
- 2023Name changeDr. Vanvaerenbergh
- 2022Annual accounts 2022-44,2 k €↓
- 2021Annual accounts 202131,2 k €↓
- 2021Name changeDr. Vanvaerenbergh Saskia, huisarts
- 2020Annual accounts 202050,7 k €↑
- 2019Annual accounts 201920,2 k €↓
- 2018Annual accounts 201829,9 k €↑
- 2017Annual accounts 201722,6 k €↓
- 2016Annual accounts 201646,7 k €↑
- 2015Annual accounts 2015-6,8 k €↓
- 2014Annual accounts 201415,8 k €↑
- 2013Annual accounts 201311,3 k €↓
- 2012Annual accounts 201223,5 k €↑
- 2011Annual accounts 201112 k €